Center-Authored Papers

Filters: Author is Garland, Linda L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Public Health Sciences Division
Garland LL, Chansky K, Wozniak AJ, Tsao AS, Gadgeel SM, Verschraegen CF, Dasilva MA, Redman MW, Gandara DR.  2011.  Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(11):1938-45. Abstract
October 2011
Garland LL, Chansky K, Wozniak AJ, Tsao AS, Gadgeel SM, Verschraegen CF, Dasilva MA, Redman MW, Gandara DR.  2011.  Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(11):1938-45. Abstract
Center-Authored Paper
Garland LL, Chansky K, Wozniak AJ, Tsao AS, Gadgeel SM, Verschraegen CF, Dasilva MA, Redman MW, Gandara DR.  2011.  Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(11):1938-45. Abstract
2011
Garland LL, Chansky K, Wozniak AJ, Tsao AS, Gadgeel SM, Verschraegen CF, Dasilva MA, Redman MW, Gandara DR.  2011.  Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 6(11):1938-45. Abstract